Apple Forecast, price target & analysts
Apple Target price 2026 - Analyst rating & recommendation
Apple Classifications & Recommendation
Apple Price Target
| Target Price | $336.60 |
| Price | $342.37 |
| Deviation | 1.69% |
| Number of Estimates | 43 |
| 43 Analysts have issued a price target Apple 2027 . The average Apple target price is $336.60. This is 1.69% lower than the current stock price. The highest price target is $425.25 24.21% , the lowest is $217.15 36.57% . | |
| A rating was issued by 49 analysts: 30 Analysts recommend Apple to buy, 15 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Apple stock has an average upside potential 2027 of 1.69% . Most analysts recommend the Apple stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2031
45 Analysts have issued a sales forecast Apple 2027 . The average Apple sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
31 Analysts have issued an Apple EBITDA forecast 2027. The average Apple EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
45 Apple Analysts have issued a net profit forecast 2027. The average Apple net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031
Current Apple Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Buy
|
Unchanged | Nov 03 2026 |
| Barclays |
Underweight
➜
Underweight
|
Unchanged | Nov 03 2026 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Nov 03 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Nov 03 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Nov 03 2026 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Nov 03 2026 |
| Keybanc |
Underweight
➜
Underweight
|
Unchanged | Nov 03 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Nov 03 2026 |
|
Unchanged
Barclays:
Underweight
➜
Underweight
|
Nov 03 2026 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Nov 03 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Nov 03 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Nov 03 2026 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Nov 03 2026 |
|
Unchanged
Keybanc:
Underweight
➜
Underweight
|
Nov 03 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
